
Aceclofenac (100mg) + Serratiopeptidase (10mg) + Paracetamol (325mg)
Active composition
+2 more active ingredients
Aceclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which are responsible for pain and inflammation.
Serratiopeptidase acts as a proteolytic enzyme, breaking down fibrin and other proteins involved in inflammation, thereby reducing pain and swelling.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Oxypara-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (10mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis. Paracetamol provides analgesic and antipyretic effects by acting centrally to inhibit prostaglandin production, complementing the anti-inflammatory action of Aceclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators, promoting the reduction of swelling and enhancing tissue repair. This combination is indicated for the management of acute and chronic musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative pain, and soft tissue injuries such as sprains and strains. Oxypara-SP offers rapid and sustained relief from pain and inflammation, improving patient mobility and quality of life. It is generally well-tolerated; however, caution is advised in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs. The medication should be used under medical supervision, with adherence to prescribed dosages to minimize adverse effects such as gastrointestinal discomfort, allergic reactions, or hepatic enzyme alterations. Oxypara-SP Tablet represents an effective therapeutic option for multimodal pain management.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Oxypara-SP Tablet

Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Aceclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which are responsible for pain and inflammation.
Serratiopeptidase acts as a proteolytic enzyme, breaking down fibrin and other proteins involved in inflammation, thereby reducing pain and swelling.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Oxypara-SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac (100mg), Paracetamol (325mg), and Serratiopeptidase (10mg). Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis. Paracetamol provides analgesic and antipyretic effects by acting centrally to inhibit prostaglandin production, complementing the anti-inflammatory action of Aceclofenac. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators, promoting the reduction of swelling and enhancing tissue repair. This combination is indicated for the management of acute and chronic musculoskeletal pain, osteoarthritis, rheumatoid arthritis, postoperative pain, and soft tissue injuries such as sprains and strains. Oxypara-SP offers rapid and sustained relief from pain and inflammation, improving patient mobility and quality of life. It is generally well-tolerated; however, caution is advised in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs. The medication should be used under medical supervision, with adherence to prescribed dosages to minimize adverse effects such as gastrointestinal discomfort, allergic reactions, or hepatic enzyme alterations. Oxypara-SP Tablet represents an effective therapeutic option for multimodal pain management.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Oxypara-SP Tablet











